- Home
- UNCY vs HOOK Comparison
UNCY vs HOOK Comparison
Compare UNCY & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- HOOK
- Stock Information
- Founded
- UNCY 2016
- HOOK 2011
- Country
- UNCY United States
- HOOK United States
- Employees
- UNCY N/A
- HOOK N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- HOOK Biotechnology: Pharmaceutical Preparations
- Sector
- UNCY Health Care
- HOOK Health Care
- Exchange
- UNCY Nasdaq
- HOOK Nasdaq
- Market Cap
- UNCY 31.9M
- HOOK 30.2M
- IPO Year
- UNCY 2021
- HOOK 2019
- Fundamental
- Price
- UNCY $0.66
- HOOK $2.00
- Analyst Decision
- UNCY Strong Buy
- HOOK Strong Buy
- Analyst Count
- UNCY 4
- HOOK 4
- Target Price
- UNCY $5.50
- HOOK $34.50
- AVG Volume (30 Days)
- UNCY 1.5M
- HOOK 66.7K
- Earning Date
- UNCY 11-13-2024
- HOOK 11-14-2024
- Dividend Yield
- UNCY N/A
- HOOK N/A
- EPS Growth
- UNCY N/A
- HOOK N/A
- EPS
- UNCY N/A
- HOOK N/A
- Revenue
- UNCY N/A
- HOOK $49,999,000.00
- Revenue This Year
- UNCY N/A
- HOOK $147.52
- Revenue Next Year
- UNCY N/A
- HOOK N/A
- P/E Ratio
- UNCY N/A
- HOOK N/A
- Revenue Growth
- UNCY N/A
- HOOK 143.30
- 52 Week Low
- UNCY $0.20
- HOOK $1.88
- 52 Week High
- UNCY $1.82
- HOOK $11.30
- Technical
- Relative Strength Index (RSI)
- UNCY 52.04
- HOOK 26.63
- Support Level
- UNCY $0.62
- HOOK $2.01
- Resistance Level
- UNCY $0.87
- HOOK $2.27
- Average True Range (ATR)
- UNCY 0.08
- HOOK 0.18
- MACD
- UNCY -0.01
- HOOK 0.02
- Stochastic Oscillator
- UNCY 15.45
- HOOK 31.94
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.